Shares of Cameco Corp (NYSE: CCJ) Tuesday climbed over 1% on Tuesday, adding to recent gains and taking the stock higher by more than 36% year to date.
Uranium prices have skyrocketed since Russia invaded Ukraine, and one analyst said Tuesday that investors can expect upward pricing pressure on uranium to persist for the foreseeable future.
Cameco (NYSE:CCJ) has outperformed the market over the past 20 years by 2.22% on an annualized basis producing an average annual return of 9.42%. Currently, Cameco has a market capitalization of $11.54 billion.
Declining global uranium inventory levels may lend upside support to Cameco Corp.’s (NYSE: CCJ) stock, according to BMO Capital Markets.
The Cameco Analyst: Alexander Pearce upgraded the rating for Cameco to Outperform, while raising the price target to C$42 (U.S.$33.63).
On CNBC’s “Halftime Report Final Trades,” Karen Firestone of Aureus Asset Management said HealthEquity Inc’s (NASDAQ: HQY) stock had “a terrible year” in 2021.